Coca-Cola Consolidated
COKE
188.05
-6.56
-3.37%
Coca-Cola Consolidated
US · COKE
#1269 by market cap
Listed 1970
188.05
-6.56
-3.37%
Live - 5344 symbols - heartbeat 135s ago
· 2026-10-08 07:38
Pre-market
190.47
+1.29%
After-hours
189.31
+0.67%
Overnight
188.85
+0.43%
- Market cap
- 12.52B
- P/E (TTM)i
- 24.97
- P/Bi
- -25.03
- EPSi
- 6.81
- Div yieldi
- 0.53%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on COKE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.71, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.76% YoY
Margins
- Gross margin
- 39.74%
- Operating margin
- 13.15%
- Net margin
- 7.89%
Key ratios & quality
- Enterprise valuei
- 15.05B
- PEG ratioi
- 2.53
- Altman Z-Scorei
- 3.71
PEG uses trailing P/E against the 3-year net income growth rate (9.87%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.63B | 4.83B | 5.01B | 5.56B | 6.20B | 6.65B | 6.90B | 7.23B |
| Gross profit | 1.56B | 1.67B | 1.77B | 1.95B | 2.28B | 2.60B | 2.75B | 2.87B |
| Selling & admin expenses | 1.50B | 1.49B | 1.46B | 1.52B | 1.64B | 1.76B | 1.83B | 1.92B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 57.90M | 180.75M | 313.38M | 439.17M | 641.05M | 834.45M | 920.35M | 950.66M |
| Pretax profit | -13.29M | 34.23M | 241.04M | 255.15M | 575.09M | 557.48M | 856.65M | 772.92M |
| Tax | 1.87M | 15.67M | 58.94M | 65.57M | 144.93M | 149.11M | 223.53M | 202.34M |
| Net profit | -15.16M | 18.56M | 182.10M | 189.58M | 430.16M | 408.38M | 633.13M | 570.58M |
| Basic EPS | 0 | 0 | 2 | 2 | 5 | 4 | 7 | 7 |
| Diluted EPS | -0.21 | 0.12 | 1.83 | 2.02 | 4.57 | 4.35 | 6.99 | 6.81 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.58B | 1.86B | 1.89B | 1.90B | 1.85B | 2.05B |
| Gross profit | 627.10M | 742.50M | 748.52M | 754.25M | 727.08M | 778.41M |
| Selling & admin expenses | 437.28M | 470.41M | 501.88M | 512.13M | 489.56M | 507.07M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 189.82M | 272.08M | 246.63M | 242.12M | 237.52M | 271.34M |
| Pretax profit | 139.47M | 252.99M | 192.23M | 188.22M | 151.22M | 215.12M |
| Tax | 35.86M | 65.61M | 49.90M | 50.97M | 39.66M | 56.30M |
| Net profit | 103.61M | 187.39M | 142.33M | 137.25M | 111.56M | 158.82M |
| Basic EPS | 1 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.19 | 2.15 | 1.64 | 1.84 | 1.67 | 2.38 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 797.42M | 830.28M | 851.24M | 1.08B | 1.25B | 1.71B | 2.55B | 1.43B |
| Cash & ST investments | 13.55M | 9.61M | 54.79M | 142.31M | 197.65M | 635.27M | 1.44B | 281.92M |
| Inventory | 210.03M | 225.93M | 225.76M | 302.85M | 347.55M | 321.93M | 330.40M | 336.40M |
| Total assets | 3.01B | 3.13B | 3.22B | 3.45B | 3.71B | 4.29B | 5.31B | 4.30B |
| Total current liabilities | 601.74M | 622.20M | 647.06M | 834.86M | 905.16M | 1.09B | 1.31B | 1.13B |
| Short-term debt | 8.62M | 24.43M | 25.63M | 28.11M | 29.94M | 28.68M | 375.64M | 124.97M |
| Long-term debt | 1.10B | 1.03B | 940.47M | 723.44M | 598.82M | 599.16M | 1.44B | 2.69B |
| Total liabilities | 2,554,762,000.00 | 2,675,810,000.00 | 2,709,460,000.00 | 2,733,784,000.00 | 2,594,157,000.00 | 2,853,344,000.00 | 3,895,528,000.00 | 5,042,721,000.00 |
| Total equity | 455.17M | 451.12M | 512.99M | 711.79M | 1.12B | 1.44B | 1.42B | -739.72M |
| Retained earnings | 359.44M | 381.16M | 544.28M | 724.49M | 1.11B | 1.35B | 1.40B | -824.05M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.61B | 2.73B | 2.85B | 1.43B | 1.50B | 1.53B |
| Cash & ST investments | 1.49B | 1.57B | 1.68B | 281.92M | 232.95M | 171.69M |
| Inventory | 340.21M | 349.17M | 354.86M | 336.40M | 388.74M | 371.19M |
| Total assets | 5.40B | 5.54B | 5.67B | 4.30B | 4.39B | 4.43B |
| Total current liabilities | 1.29B | 1.34B | 1.39B | 1.13B | 1.22B | 1.26B |
| Short-term debt | 375.64M | 376.06M | 375.04M | 124.97M | 124.55M | 124.06M |
| Long-term debt | 1.44B | 1.44B | 1.44B | 2.69B | 2.54B | 2.41B |
| Total liabilities | 3,904,324,000.00 | 3,911,272,000.00 | 4,032,586,000.00 | 5,042,721,000.00 | 5,036,178,000.00 | 4,932,605,000.00 |
| Total equity | 1.50B | 1.63B | 1.64B | -739.72M | -643.47M | -500.13M |
| Retained earnings | 1.48B | 1.64B | 1.52B | -824.05M | -729.13M | -586.95M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 168.88M | 290.37M | 494.46M | 521.76M | 554.51M | 810.69M | 876.36M | 931.90M |
| Depreciation & amortization | 187.26M | 179.92M | 179.02M | 180.57M | 171.59M | 176.97M | 193.79M | 218.53M |
| Free cash flow | 30.64M | 114.34M | 292.43M | 357.07M | 225.25M | 528.39M | 505.34M | 619.59M |
| Dividends paid | -9.35M | -9.37M | -9.37M | -9.37M | -9.37M | -46.87M | -185.64M | -86.67M |
| Stock buybacks / issuance | -- | -- | -- | -- | 0 | 0 | -625.65M | -2.61B |
| Ending cash balance | 13.55M | 9.61M | 54.79M | 142.31M | 197.65M | 635.27M | 1.14B | 281.92M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 198.17M | 208.05M | 316.69M | 208.99M | 205.27M | 215.37M |
| Depreciation & amortization | 53.37M | 54.77M | 55.09M | 55.31M | 56.90M | 58.15M |
| Free cash flow | 100.31M | 148.53M | 264.08M | 106.67M | 142.16M | 131.13M |
| Dividends paid | -21.79M | -21.80M | -21.72M | -21.36M | -16.64M | -16.64M |
| Stock buybacks / issuance | -- | -- | -111.29M | -2.46B | -- | -- |
| Ending cash balance | 1.15B | 1.22B | 1.53B | 281.92M | 232.95M | 171.69M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -5.50 | 3.23 | 40.12 | 30.96 | 47.08 | 32.02 | 44.38 | 168.34 |
| ROA %i | -0.66 | 0.37 | 5.43 | 5.69 | 12.02 | 10.21 | 13.19 | 11.87 |
| ROIC %i | 1.13 | 2.98 | 12.57 | 12.92 | 25.49 | 20.18 | 23.09 | 21.93 |
| 5-year avg ROE %i | 17.63 | 14.93 | 17.42 | 19.76 | 23.18 | 30.68 | 38.91 | 64.56 |
| EBIT margin %i | 0.80 | 1.66 | 5.55 | 5.19 | 9.67 | 12.54 | 12.44 | 11.28 |
| FCF / sales %i | 0.66 | 2.37 | 5.84 | 6.42 | 3.63 | 7.94 | 7.32 | 8.57 |
| Current ratioi | 1.33 | 1.33 | 1.32 | 1.29 | 1.38 | 1.56 | 1.94 | 1.26 |
| Quick ratioi | 0.87 | 0.86 | 0.84 | 0.83 | 0.89 | 1.19 | 1.61 | 0.87 |
| Debt / assetsi | 37.86 | 37.40 | 35.87 | 27.24 | 20.35 | 17.14 | 35.89 | 67.56 |
| LT debt / equityi | 315.77 | 330.04 | 220.35 | 127.92 | 65.01 | 49.21 | 108.02 | -- |
| Interest coveragei | 0.74 | 1.74 | 7.56 | 8.63 | 24.20 | -- | 464.56 | 19.11 |
| Revenue CAGR (3Y) %i | 26.11 | 15.53 | 5.31 | 6.34 | 8.71 | 9.94 | 7.44 | 5.24 |
| Net income CAGR (3Y) %i | -- | -39.01 | 21.35 | -- | 235.65 | 33.28 | 49.47 | 9.87 |
| FCF CAGR (3Y) %i | -- | -- | 36.25 | 126.71 | 25.36 | 21.80 | 12.27 | 40.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 36.83 | 41.45 | 41.92 | 168.34 | 135.18 | 97.33 |
| ROA %i | 11.77 | 10.46 | 11.19 | 11.87 | 11.81 | 11.03 |
| ROIC %i | 19.93 | 17.65 | 18.18 | 21.93 | 22.81 | 19.45 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.46 | 12.17 | 12.24 | 11.28 | 11.38 | 11.21 |
| FCF / sales %i | 7.09 | 6.86 | 8.45 | 8.57 | 8.83 | 8.37 |
| Current ratioi | 2.03 | 2.04 | 2.04 | 1.26 | 1.23 | 1.21 |
| Quick ratioi | 1.69 | 1.71 | 1.72 | 0.87 | 0.81 | 0.83 |
| Debt / assetsi | 35.20 | 34.33 | 33.81 | 67.56 | 62.67 | 59.18 |
| LT debt / equityi | 101.80 | 93.64 | 94.22 | -- | -- | -- |
| Interest coveragei | -- | -- | -- | 19.11 | 12.56 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Nonalcoholic Beverages is the largest reported line at 99.34% of revenue, across 3 reported segments.
- The next-largest line, All other, is a distant second at 4.50% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Nonalcoholic Beverages99.34%
All other4.50%
Quote time 2026-10-08 07:38:25 · For reference only, not investment advice and not tailored to your situation.